Fenoget®

Fenoget®

Therapeutic Segment: Anti-Lipidemic

Generic Name: Fenofibrate

Indication:

For:

  • Primary Hypercholesterolemia and Mixed Dyslipidemia as adjunctive therapy to diet to
    reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG), and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hyperlipidemia or mixed dyslipidemia.
  • Hypertriglyceridemia as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia.

Available as:

Capsules
  • 67MG
  • 200MG